Subtle microstructural changes of the striatum in a DYT1 knock-in mouse model of dystonia

Neurobiology of Disease

Volumn 54, Issue , 2013, Pages 362-371

  Song, Chang Hyun ^a,c   Bernhard, Douglas ^a   Bolarinwa, Caroline ^a   Hess, Ellen J ^a   Smith, Yoland ^a   Jinnah, H A ^a,b  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b EMORY UNIVERSITY   (United States)

^c Daegu Haany University   (South Korea)

Author keywords

Anatomy; Electron microscopy; Golgi histochemistry; Mouse mutant; Stereology; Striatum

Indexed keywords

CHOLINE ACETYLTRANSFERASE; NEURONAL NITRIC OXIDE SYNTHASE; PARVALBUMIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CHOLINERGIC NERVE CELL; CONTROLLED STUDY; CORPUS STRIATUM; DENDRITE; DENDRITIC SPINE; DYSTONIA; DYT1 GENE; ELECTRON MICROSCOPY; FEMALE; GENE; GOLGI STAIN; IMMUNOELECTRON MICROSCOPY; IMMUNOHISTOCHEMISTRY; INTERNEURON; MALE; MOUSE; NERVE PROJECTION; NEUROPATHOLOGY; NISSL STAINING; NONHUMAN; PRIORITY JOURNAL; SYNAPSE;

ANIMALS; CORPUS STRIATUM; DISEASE MODELS, ANIMAL; DYSTONIC DISORDERS; GENE KNOCK-IN TECHNIQUES; IMMUNOHISTOCHEMISTRY; MICE; MICE, INBRED C57BL; MICROSCOPY, IMMUNOELECTRON; MOLECULAR CHAPERONES; NEURONS;

EID: 84876346215     PISSN: 09699961     EISSN: 1095953X     Source Type: Journal    
DOI: 10.1016/j.nbd.2013.01.008     Document Type: Article

References (64)

1. Argyelan M., et al. Cerebellothalamocortical connectivity regulates penetrance in dystonia. J. Neurosci. 2009, 29:9740-9747.
2. Bolam J.P., Smith Y. The GABA and substance P input to dopaminergic neurones in the substantia nigra of the rat. Brain Res. 1990, 529:57-78.
3. Bonhoeffer T., Yuste R. Spine motility. Phenomenology, mechanisms, and function. Neuron 2002, 35:1019-1027.
4. Breakefield X.O., et al. The pathophysiological basis of dystonias. Nat. Rev. Neurosci. 2008, 9:222-234.
5. Carbon M., et al. Functional imaging in hereditary dystonia. Eur. J. Neurol. 2010, 17(Suppl. 1):58-64.
6. Carbon M., et al. Increased sensorimotor network activity in DYT1 dystonia: a functional imaging study. Brain 2010, 133:690-700.
7. Dang M.T., et al. Generation and characterization of Dyt1 DeltaGAG knock-in mouse as a model for early-onset dystonia. Exp. Neurol. 2005, 196:452-463.
8. Dang M.T., et al. An anticholinergic reverses motor control and corticostriatal LTD deficits in Dyt1 DeltaGAG knock-in mice. Behav. Brain Res. 2012, 226:465-472.
9. de Carvalho Aguiar P.M., Ozelius L.J. Classification and genetics of dystonia. Lancet Neurol. 2002, 1:316-325.
10. Draganski B., et al. Genotype-phenotype interactions in primary dystonias revealed by differential changes in brain structure. NeuroImage 2009, 47:1141-1147.
11. Egami K., et al. Basal ganglia dopamine loss due to defect in purine recycling. Neurobiol. Dis. 2007, 26:396-407.
12. Fahn S. Concept and classification of dystonia. Adv. Neurol. 1988, 50. (8-Jan.).
13. Fiala J.C., et al. Dendritic spine pathology: cause or consequence of neurological disorders?. Brain Res. Brain Res. Rev. 2002, 39:29-54.
14. Gernert M., et al. Deficit of striatal parvalbumin-reactive GABAergic interneurons and decreased basal ganglia output in a genetic rodent model of idiopathic paroxysmal dystonia. J. Neurosci. 2000, 20:7052-7058.
15. Goodchild R.E., et al. Loss of the dystonia-associated protein torsinA selectively disrupts the neuronal nuclear envelope. Neuron 2005, 48:923-932.
16. Graybiel A.M., et al. Cholinergic neuropil of the striatum observes striosomal boundaries. Nature 1986, 323:625-627.
17. Grundmann K., et al. Overexpression of human wildtype torsinA and human DeltaGAG torsinA in a transgenic mouse model causes phenotypic abnormalities. Neurobiol. Dis. 2007, 27:190-206.
18. Harris K.M., Kater S.B. Dendritic spines: cellular specializations imparting both stability and flexibility to synaptic function. Annu. Rev. Neurosci. 1994, 17:341-371.
19. Irwin S.A., et al. Dendritic spine structural anomalies in fragile-X mental retardation syndrome. Cereb. Cortex. 2000, 10:1038-1044.
20. Jinnah H.A., et al. Rodent models for dystonia research: characteristics, evaluation, and utility. Mov. Disord. 2005, 20:283-292.
21. Kawaguchi Y., et al. Striatal interneurones: chemical, physiological and morphological characterization. Trends Neurosci. 1995, 18:527-535.
22. Kemp J.M., Powell T.P. The termination of fibres from the cerebral cortex and thalamus upon dendritic spines in the caudate nucleus: a study with the Golgi method. Philos. Trans. R. Soc. Lond. B Biol. Sci. 1971, 262:429-439.
23. Kreitzer A.C. Physiology and pharmacology of striatal neurons. Annu. Rev. Neurosci. 2009, 32:127-147.
24. Luk K.C., Sadikot A.F. GABA promotes survival but not proliferation of parvalbumin-immunoreactive interneurons in rodent neostriatum: an in vivo study with stereology. Neuroscience 2001, 104:93-103.
25. Luo L., O'Leary D.D. Axon retraction and degeneration in development and disease. Annu. Rev. Neurosci. 2005, 28:127-156.
26. Marrone M.C., et al. Altered cortico-striatal synaptic plasticity and related behavioural impairments in reeler mice. Eur. J. Neurosci. 2006, 24:2061-2070.
27. Martella G., et al. Impairment of bidirectional synaptic plasticity in the striatum of a mouse model of DYT1 dystonia: role of endogenous acetylcholine. Brain 2009, 132:2336-2349.
28. McNaught K.S., et al. Brainstem pathology in DYT1 primary torsion dystonia. Ann. Neurol. 2004, 56:540-547.
29. McNeill T.H., et al. Quantitative analysis of age-related dendritic changes in medium spine I (MSI) striatal neurons of C57BL/6N mice. Neurobiol. Aging 1990, 11:537-550.
30. Mikolaenko I., et al. A Golgi study of neuronal architecture in a genetic mouse model for Lesch-Nyhan disease. Neurobiol. Dis. 2005, 20:479-490.
31. Nemeth A.H. The genetics of primary dystonias and related disorders. Brain 2002, 125:695-721.
32. Neychev V.K., et al. The functional neuroanatomy of dystonia. Neurobiol. Dis. 2011, 42:185-201.
33. Oorschot D.E. Total number of neurons in the neostriatal, pallidal, subthalamic, and substantia nigral nuclei of the rat basal ganglia: a stereological study using the cavalieri and optical disector methods. J. Comp. Neurol. 1996, 366:580-599.
34. Paxinos G., Franklin K.B.J. The Mouse Brain in Stereotaxic Coordinates 2004, Elsevier Academic Press, Amsterdam; Boston.
35. Peters A., et al. The Fine Structure of the Nervous System: Neurons and Their Supporting Cells 1991, Oxford University Press, New York.
36. Pisani A., et al. Altered responses to dopaminergic D2 receptor activation and N-type calcium currents in striatal cholinergic interneurons in a mouse model of DYT1 dystonia. Neurobiol. Dis. 2006, 24:318-325.
37. Pisani A., et al. Re-emergence of striatal cholinergic interneurons in movement disorders. Trends Neurosci. 2007, 30:545-553.
38. Prudente C.N., et al. Neuropathology of cervical dystonia. Exp Neurol 2013, 241:95-104.
39. Raju D.V., et al. Differential synaptic plasticity of the corticostriatal and thalamostriatal systems in an MPTP-treated monkey model of parkinsonism. Eur. J. Neurosci. 2008, 27:1647-1658.
40. Rostasy K., et al. TorsinA protein and neuropathology in early onset generalized dystonia with GAG deletion. Neurobiol. Dis. 2003, 12:11-24.
41. Sander S.E., et al. Age-related changes in striatal nitric oxide synthase-immunoreactive interneurones in the dystonic dtsz mutant hamster. Neuropathol. Appl. Neurobiol. 2006, 32:74-82.
42. Schwarz C.S., Bressman S.B. Genetics and treatment of dystonia. Neurol. Clin. 2009, 27:697-718. (vi).
43. Sciamanna G., et al. Developmental profile of the aberrant dopamine D2 receptor response in striatal cholinergic interneurons in DYT1 dystonia. PLoS One 2011, 6:e24261.
44. Sciamanna G., et al. Cholinergic dysregulation produced by selective inactivation of the dystonia-associated protein torsinA. Neurobiol. Dis. 2012, 47:416-427.
45. Sciamanna G., et al. Cholinergic dysfunction alters synaptic integration between thalamostriatal and corticostriatal inputs in DYT1 dystonia. J. Neurosci. 2012, 32:11991-12004.
46. Sharma N., et al. Impaired motor learning in mice expressing torsinA with the DYT1 dystonia mutation. J. Neurosci. 2005, 25:5351-5355.
47. Shashidharan P., et al. Transgenic mouse model of early-onset DYT1 dystonia. Hum. Mol. Genet. 2005, 14:125-133.
48. Sholl D.A. Dendritic organization in the neurons of the visual and motor cortices of the cat. J. Anat. 1953, 87:387-407.
49. Smith Y., et al. Synaptic relationships between dopaminergic afferents and cortical or thalamic input in the sensorimotor territory of the striatum in monkey. J. Comp. Neurol. 1994, 344:1-19.
50. Song C.H., et al. Functional analysis of dopaminergic systems in a DYT1 knock-in mouse model of dystonia. Neurobiol. Dis. 2012, 48:66-78.
51. Standaert D.G. Update on the pathology of dystonia. Neurobiol. Dis. 2011, 42:148-151.
52. Tanabe L.M., et al. Primary dystonia: molecules and mechanisms. Nat. Rev. Neurol. 2009, 5:598-609.
53. Tarsy D., Simon D.K. Dystonia. N. Engl. J. Med. 2006, 355:818-829.
54. Tepper J.M., Bolam J.P. Functional diversity and specificity of neostriatal interneurons. Curr. Opin. Neurobiol. 2004, 14:685-692.
55. Ulug A.M., et al. Cerebellothalamocortical pathway abnormalities in torsinA DYT1 knock-in mice. Proc. Natl. Acad. Sci. U. S. A. 2011, 108:6638-6643.
56. Villalba R.M., Smith Y. Differential structural plasticity of corticostriatal and thalamostriatal axo-spinous synapses in MPTP-treated Parkinsonian monkeys. J. Comp. Neurol. 2011, 519:989-1005.
57. von Bohlen Und Halbach O. Dendritic spine abnormalities in mental retardation. Cell Tissue Res. 2010, 342:317-323.
58. Wichmann T. Commentary: dopaminergic dysfunction in DYT1 dystonia. Exp. Neurol. 2008, 212:242-246.
59. Wichmann T., Dostrovsky J.O. Pathological basal ganglia activity in movement disorders. Neuroscience 2011, 198:232-244.
60. Yamada H., et al. Neuronal mechanism underlying dystonia induced by bicuculline injection into the putamen of the cat. Brain Res. 1995, 677:333-336.
61. Yoshida M., et al. Differential roles of the caudate nucleus and putamen in motor behavior of the cat as investigated by local injection of GABA antagonists. Neurosci. Res. 1991, 10:34-51.
62. Zhang L., et al. Altered dendritic morphology of Purkinje cells in Dyt1 DeltaGAG knock-in and purkinje cell-specific Dyt1 conditional knockout mice. PLoS One 2011, 6:e18357.
63. Zhao Y., et al. Abnormal motor function and dopamine neurotransmission in DYT1 DeltaGAG transgenic mice. Exp. Neurol. 2008, 210:719-730.
64. Zoons E., et al. Structural, functional and molecular imaging of the brain in primary focal dystonia-A review. NeuroImage 2011, 56:1011-1020.